Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MGX is expected to report earnings to rise 5.88% to -72 cents per share on August 13
Q2'25
Est.
$-0.72
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.40
Q3'24
Beat
by $0.24
Q2'24
Beat
by $0.41
The last earnings report on May 14 showed earnings per share of -68 cents, beating the estimate of -75 cents. With 286.93K shares outstanding, the current market capitalization sits at 62.05M.